A detailed history of Banque Transatlantique Sa transactions in Absci Corp stock. As of the latest transaction made, Banque Transatlantique Sa holds 12,100 shares of ABSI stock, worth $33,033. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,100
Holding current value
$33,033
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$2.51 - $5.82 $30,370 - $70,422
12,100 New
12,100 $30,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $253M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Banque Transatlantique Sa Portfolio

Follow Banque Transatlantique Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Transatlantique Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Transatlantique Sa with notifications on news.